Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen

Welkom bij Scalda & Bohn Stafleu van Loghum

Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.

» Andere revante producten voor Scalda studenten en medewerkers.

Registreer

Schaf de BSL Academy aan: 

BSL Academy mbo AG

Eenmaal aangeschaft kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Heb je een vraag, neem dan contact op met Jan van der Velden.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Netherlands Heart Journal
Gepubliceerd in:

01-11-2009 | Original article

Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison

Auteurs: Y. B. Juwana, J. Wirianta, J. P. Ottervanger, J-H. E. Dambrink, AW. J. van ’t Hof, A. T. M. Gosselink, J. C. A. Hoorntje, M-J. de Boer, H. Suryapranata

Gepubliceerd in: Netherlands Heart Journal | Uitgave 11/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Extract

The most important therapeutic goal in the treatment of patients with ST-elevation myocardial Infarction (STEMI) is achievement of early and complete reperfusion of the infarct-related vessel. Effective reperfusion can be achieved by either fibrinolytic therapy or primary percutaneous coronary intervention (PCI) without antecedent fibrinolysis. A total of 23 randomised controlled trials, involving more than 7500 patients, have demonstrated the superiority of primary PCI over fibrinolytic therapy,1 with the absolute mortality advantage of primary PCI greatest in high-risk patients such as those with cardiogenic shock.2,3 However, almost all these trials were performed in the United States or Western Europe. The situation and the efficacy of primary PCI may differ in other parts of the world, with regards to logistics, experience of PCI centres and patient characteristics. More insights into potential differences between these regions and the Western world are important to estimate whether primary PCI will also be effective in these countries. …
vorige artikel Gender differences in adult congenital heart disease
volgende artikel Founder mutations in the Netherlands
Literatuur
1.
Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trial. Lancet. 2003;361:13–20.
2.
Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625–34.
3.
Zahn R, Schiele R, Schneider S, Gitt AK, Wienbergen H, Seidl K, et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? J Am Coll Cardiol. 2001;37:1827–35.
4.
Gupta M, Singh N, Verma S. South Asian and cardiovascular risk, what clinicians should know. Circulation. 2006;113:e924–9.
5.
Santoso T. Prevention of cardiovascular disease in diabetes mellitus: by stressing the CARDS study. Acta Med Indones. 2006; 38:97–102.
6.
Martiniuk AL, Lee CM, Lawes CM, Ueshima H, Suh I, Lam TH, et al; Asia-Pacific Cohort Studies Collaboration. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens. 2007;1:73–9.
7.
Martiniuk AL, Lee CM, Lam TH, Huxley R, Suh I, Jamrozik K, et al; Asia Pacific Cohort Studies Collaboration. The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions. Tob Control. 2006;15:181–8.
8.
Woodward M, Lam TH, Barzi F, Patel A, Gu D, Rodgers A, et al; Asia Pacific Cohort Studies Collaboration. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol. 2005;34:1036–45.
9.
Boedhi-Darmojo R, Setianto B, Sutedjo, Kusmana D, Andradi, Supari F, et al. A study of baseline risk factors for coronary heart disease: results of population screening in a developing country. Rev Epidemiol Sante Publique. 1990;38:487–91.
10.
Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290:86–97.
11.
Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681–8.
12.
Pan WH, Yeh WT, Weng LC. Epidemiology of metabolic syndrome in Asia. Asia Pac J Clin Nutr. 2008;17(Suppl 1):37–42.
13.
Adam FM, Adam JM, Pandeleki N, Mappangara I. Asymptomatic diabetes: the difference between population-based and officebased screening. Acta Med Indones. 2006;38:67–71.
14.
Eppens MC, Craig ME, Jones TW, Silink M, Ong S, Ping YJ; The International Diabetes Federation Western Pacific Region Steering Committee. Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications. Curr Med Res Opin. 2006;22:1013–20.
15.
De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223–5.
16.
Jacobs AK, Antman EM, Ellrodt G, Faxon DP, Gregory T, Mensah GA, et al. Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention. Circulation. 2006;113:2152–63.
17.
Stone GW. Angioplasty strategies in ST-segment–elevation myocardial infarction. Part I: primary percutaneous coronary intervention. Circulation. 2008;118:538–51.
18.
Hidayat B, Thabrany H, Dong H, Sauerborn R. The effects of mandatory health insurance on equity in access to outpatient care in Indonesia. Health Policy and Planning. 2004;19:322–35.
19.
Thabrany H, Gani A, Pujianto, Mayanda L, Mahlil, Budi BS. Center for Health Economic Studies, University of Indonesia, Presented in Social Health Insurance Workshop, WHO SEARO, New Delhi, March 13–15, 2003.
20.
De Boer MJ, van Hout BA, Liem AL, Suryapranata H, Hoorntje JCA, Zijlstra F. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol. 1995;76:830–3.
Metagegevens
Titel
Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison
Auteurs
Y. B. Juwana
J. Wirianta
J. P. Ottervanger
J-H. E. Dambrink
AW. J. van ’t Hof
A. T. M. Gosselink
J. C. A. Hoorntje
M-J. de Boer
H. Suryapranata
Publicatiedatum
01-11-2009
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 11/2009
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03086295

Andere artikelen Uitgave 11/2009

Recurrent and founder mutations in inherited cardiac diseases in the Netherlands

  • Editorial

A very rare image in cardiology: posterolateral artery myocardial bridge

  • Imaging in cardiology

Founder mutations in the Netherlands

  • Review article

Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report

  • Case report

Imaging atherosclerotic plaque composition with intracoronary optical coherence tomography

  • Interuniversity Cardiology Institute of the Netherlands

Remote monitoring of implanted cardiac devices: a plea for a nationwide exploration

  • Debate article